← Back to Clinical Trials
Recruiting NCT06414278
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
Trial Parameters
Condition Hematopoietic and Lymphatic System Neoplasm
Sponsor Masonic Cancer Center, University of Minnesota
Study Type OBSERVATIONAL
Phase N/A
Enrollment 38
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-08
Completion 2027-07-21
Interventions
Non-Interventional Study
Brief Summary
This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.
Eligibility Criteria
Inclusion Criteria: * \* ≥ 18 years of age at initiation of therapy * Planning to undergo inpatient CAR-T therapy for primary malignancy * Fluent in English (written or spoken) Exclusion Criteria: * \* Subjects with speech or hearing impediment that would make them unable to be assessed with SALSA * Subjects with diagnosed cognitive impairment prior to CAR-T therapy * Unwilling or unable to sign voluntary written consent
Related Trials
NCT06414278
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
View Trial →
NCT06569316
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
View Trial →
NCT06709404
Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
View Trial →